Avacopan
Avacopan has been studied in 1 paper since 2025: none in people yet, 1 review. No study of it in people or animals has been published yet. The newest paper, May 31, 2025: “Aging in Granulomatosis with Polyangiitis and Microscopic Polyangiitis: From Pathophysiology to Clinical Management”.
At a glance
4 trials, none about aging, 1 with no results posted.
Cells, worms or flies, mice and humans: nothing yet.
- 4 trials, none about aging, 1 with no results posted
Who is developing avacopan?
1 company: Amgen.
- Companies
- AmgenPhase 3ANCA-associated vasculitis
Trial sponsors
Company2 trialsPhase 3363 people
2 trialsPhase 222 people
Latest
1 paper in 12 monthsClinical and Experimental Nephrology
Impact of frailty on prognosis in elderly patients with organ-threatening ANCA-associated vasculitis
Cohort study of 23 peopleBiomarkers